Breast Cancer Research Tools

At OriGene, we understand the complexity of breast cancer research. That's why we've curated a comprehensive suite of cutting-edge tools meticulously designed to empower researchers, clinicians, and scientists in their pursuit of deeper insights, effective therapies, and breakthrough discoveries. We offer the following research tools:

  • cDNA Clones: For over-expression studies, functional analysis, & protein production. View More.
  • Clone Sets: For high-throughput screening and pathway studies. View More.
  • Antibodies: For immunohistochemistry, western blotting, and immunofluorescence assays. View More.
  • Recombinant Proteins: For studying protein-protein interactions studies, biochemical assays, and biomarker identification. View More.
  • MicroRNA: For investigating miRNA involvement in breast cancer progression, metastasis, and as potential therapeutic targets. View More.
  • siRNA Oligo Duplexes: For transient gene knockdown studies. View More.
  • shRNA Plasmid Kits: For long-term gene silencing studies, loss-of-function experiments, and creating stable cell lines for research. View More.
  • Transduction-Ready Viral Particles: Lenti & AAV available for delivering genetic material to cells that are hard to transfect (i.e. Stem Cells). View More.
  • CRISPR Knockout Kits: For precise gene knockout studies, loss-of-function studies, and creating stable cell lines for research. View More.
  • Tissues: For histological analysis, protein analysis, and drug screening studies. View More.

Popular Breast Cancer Gene Targets

ALDH1 AR ATM BARD1 BRCA1 BRCA2 BRIP1 Cadherin CASP8 Caveolin CD44 CDH1 CHEK2 Claudin CTLA4 CYP19A1 Cytokeratin EGFR ESR1 FGFR2 GRB7 H19 HER2 LSP1 MAP3K1 MRE11A MUC1 NBN P53 PALB2 PGR PTEN RAD51 RAD51C RAD51D

cDNA Clones for Breast Cancer Research

Directions: Enter your gene name and select one item from each dropdown option, then press submit to view the plasmids we offer for your research.

Don't see what you're looking for? Check out our custom cloning service here.

Featured Brand – TrueORF® Gold Plasmids

OriGene’s TrueORF® Gold plasmids are an invaluable resource in genetic research. With a selection of over 18,000 meticulously curated plasmids tailored for human genes, these clones epitomize reliability and accuracy. Each clone undergoes stringent validation processes, including expression validation and sequence verification, ensuring their fidelity and functionality. These clones are also available with next-day shipping, allowing researchers to save time and start their experiments as soon as possible!

Furthermore, OriGene's comprehensive catalog of clones have earned the trust of researchers worldwide, gathering over 10,000 citations. View citations.

True ORF Gold
p53
p53 (TP53) (NM_000546) Human Tagged ORF Clone

Anti-TP53 mouse monoclonal antibody ([TA502870]) immunofluorescent staining of COS7 cells transiently transfected by our TrueORF Gold TP53 plasmid ([RC200003]).


Clone Sets for Breast Cancer Research

OriGene offers a diverse array of clone sets comprising of sequence-verified and expression-ready clones. Researchers studying the complexities of breast cancer can utilize these clone sets to study gene pathways involved in tumorigenesis and disease progression. Pre-assembled clone sets and custom options are available.

Pre-Assembled Clone Sets

Gene Families SKU Description Layout
Transcription Factors TCTF101 Human transcription factors clone set I, containing 90 cDNA clones in mammalian expression vector
TCTF102 Human transcription factors clone set II, containing 90 cDNA clones in mammalian expression vector
Protein Kinases TCPK101 Human protein kinases clone set I, containing 90 cDNA clones in mammalian expression vector
TCPK102 Human protein kinases clone set II, containing 90 cDNA clones in mammalian expression vector
GPCR TCGR101 Human GPCR clone set I, containing 90 cDNA clones in mammalian expression vector
TCGR102 Human GPCR clone set II, containing 90 cDNA clones in mammalian expression vector
Secreted TCSP101 Human secreted gene clone set I, containing 90 cDNA clones in mammalian expression vector
TCSP102 Human secreted gene clone set II, containing 90 cDNA clones in mammalian expression vector
Transmembrane TCTM101 Human transmembrane clone set I, containing 90 cDNA clones in mammalian expression vector
TCTM102 Human transmembrane clone set II, containing 90 cDNA clones in mammalian expression vector

Create Your Own Clone Sets by Selecting from a Pre-selected Pathway List

custom clone set workflow
cloneset-request
Request a quote!
Gene Families TrueORF (Myc-DDK Tagged) TrueClone (Untagged)
Breast Cancer View List View List
Breast Cancer & Estrogen Receptor Signaling View List View List
MAP Kinase Signaling Pathways View List View List
MAPK Cascade View List View List
MAPK signaling pathway KEGG View List View List
p38 MAPK signaling pathway View List View List
P53 View List View List
p53 Signaling Pathway View List View List
Regulation of Actin Cytoskeleton KEGG View List View List
Tumor Metastasis View List View List

View more pathway lists here.


Antibodies for Breast Cancer Research

Our antibody portfolio ensures specificity and reliability in diverse applications, from immunohistochemistry to immunofluorescence, western blots and more. Explore our catalog to discover essential tools for your breast cancer research journey.

Directions: Enter your gene name and select one item from each dropdown option, then press submit to view the antibodies we offer for your research.

Don't see what you're looking for? Check out our custom antibody development service here.

Featured Brand – UltraMAB® Antibodies

UltraMAB® antibodies ensure unparalleled specificity and accuracy. These ultra-specific antibodies are validated against over 17,000 human antigens using a high-density protein microarray, ensuring that there is limited cross reactivity. View details of High-Density Protein Microarray.

OriGene's antibodies have made a significant impact in scientific research, reflected by their extensive citation in academic literature. With over 9,000 citations, OriGene's antibodies have become a cornerstone in diverse fields of study, including but not limited to oncology, immunology, neuroscience, and developmental biology. View citations.

UltraMAB
um500099
CD44 Mouse Monoclonal Antibody [Clone ID: UMAB134]

Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human breast tissue using anti-CD44 mouse monoclonal antibody. ([UM500099]; heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120°C for 3min) (1:500).


Protein Biomarkers for Breast Cancer Research

Powered by our TrueORF® human cDNA clones, OriGene offers full-length human proteins expressed in HEK293 cells and other systems. These proteins serve as indispensable positive controls in ELISA and antibody assays focused on breast cancer markers, ensuring the reliability and precision of experimental outcomes in studying this complex disease. Furthermore, OriGene's recombinant proteins facilitate investigations into protein-protein interactions specific to breast cancer-related pathways, shedding light on critical mechanisms driving the disease.

Directions: Enter your gene name and select one item from each dropdown option, then press submit to view the proteins we offer for your research.

Don't see what you're looking for? Check out our custom protein service here.

Featured Brand – MVPro® Proteins

MVPro® proteins are full-length, recombinant human proteins expressed in HEK293T cells. Their properties are very close to native proteins, making them idea for antibody development, immuno-assays, & structure-function studies.

OriGene recombinant proteins have been mentioned in over 1,400 citations, a testament to their reliability and widespread recognition within the scientific community. This wealth of citations underscores the pivotal role our proteins play in advancing scientific exploration and innovation. View citations.

MVPro® proteinsTP313277
Estrogen Receptor 1 (ESR1) (NM_000125) Human Recombinant Protein

Coomassie blue staining of purified ESR1 protein (Cat# [TP313277]). The protein was produced from HEK293T cells transfected with ESR1 cDNA clone (Cat# [RC213277]) using MegaTran 2.0 (Cat# [TT210002]).


MicroRNA in Breast Cancer [1]

microRNAs are small non-coding RNA molecules that play a significant role in regulation of gene expression via RNA silencing and post-transcriptional regulation pathways. In breast cancer, differential expression of miRNA plays a critical role in regulating the invasion process by influencing cytoskeletal structure, cell-cell adhesion junctions, cancer cell-ECM interaction, tumor microenvironment, EMT transition and cancer stem cell abilities. Understanding miRNA's role in breast cancer will enable a better management of breast cancer metastasis.

Human miRNAs in breast cancer:

Up regulated:
hsa-miR-21 hsa-miR-29b hsa-miR-155
Down regulated:
hsa-miR-10b hsa-miR-125 hsa-miR-14

Refer to the table below for a list of all microRNAs involved in breast cancer

Name of miRNA miRNA expression pattern Target Genes affected by miRNA miRNA Role in Invasion-Metastasis Cascade
miR-142-3p UP ITGAV, WASL, RAC1, CFL2 Cancer cell invasiveness inhibition
miR-495 UP JAM-A Cancer cell migration
miR-10b UP HOXD10 Cell migration and invasion
miR-373 UP ITGA2 Cell migration, metastasis
miR-103/107 UP DICER1 EMT, cell migration, metastasis
miR-661 UP NECTIN1, STARD10 EMT, invasion
miR-221/222 UP TRPS1 EMT, invasion and migration (basal-like BC)
miR-23a UP CDH1 EMT, metastasis
miR-374a UP WIF1, PTEN, WNT5A EMT, metastasis
miR-22 UP TET1-3 EMT, stemness
miR-155 UP RHOA EMT, tight junction dissolution, migration and invasion
miR-191/425 UP DICER1 Invasion and metastasis
miR-221 UP CDH1 Invasion and metastasis
miR-221 UP DNMT3B Pluripotency and stemness
miR-21 UP TPM1 Tumor growth and malignant phenotype
miR-145 DOWN JAM-A Cancer cell motility inhibition
miR-145 DOWN JAM-A Cancer cell motility inhibition
miR-198 DOWN CDCP1 Cell adhesion and migration inhibition
miR-154 DOWN ADAM9 Cell migration and invasion inhibition
miR-200a DOWN CX43 Cell migration and metastasis inhibition
miR-206 DOWN CX43 Cell migration and metastasis inhibition
miR-181a-5p DOWN MMP14 Cell migration inhibition
miR-539 DOWN LAMA4 Cell migration inhibition (TNBC)
miR-7 DOWN PAK1 Cell motility and invasiveness inhibition
miR-494 DOWN PAK1 Clonogenic ability and cell migration, invasion and metastasis inhibition
miR-29b DOWN VEGFA, ANGPTL4, PDGF, LOX, MMP9 EMC re-modeling and metastasis inhibition
miR-200c DOWN ZEB1, TKS5, MYLK EMT and invadopodia forming inhibition
miR-153 DOWN MTDH EMT and invasion inhibition
miR-124 DOWN SNAI2 EMT and metastasis inhibition
miR-200b DOWN FERMT2 EMT and metastasis inhibition
miR-34 DOWN SNAI1 EMT inhibition
miR-205 DOWN ZEB1, ZEB2 EMT inhibition
miR-375 DOWN SHOX2 EMT inhibition
miR-506 DOWN SNAI2, VIM, CD151 EMT, adhesion, invasion, and migration inhibition
miR-30a DOWN ZEB2 EMT, invasion and distal spreading inhibition (TNBC)
miR-203 DOWN SNAI1 EMT, invasion and metastasis inhibition
miR-34c DOWN NOTCH4 EMT, migration and self-renewal inhibition
miR-320 DOWN ETS2 Inhibition of tumor micro-environment re-programming
miR-200 cluster DOWN WAVE3 Invasion and cell migration inhibition
miR-33a DOWN ADAM9 Invasion and metastasis inhibition
miR-193b DOWN uPA Invasion and metastasis inhibition
miR-335 DOWN TNC, SOX4 Invasion and metastasis inhibition
miR-720 DOWN TWIST1 Invasion and metastasis inhibition
miR-126 DOWN ADAM9 Invasion inhibition
miR-181a DOWN uPA Invasion inhibition
miR-193a/b DOWN uPA Invasion inhibition
miR-221/222 DOWN ITGB4, STAT5A, ADAM17 Invasion inhibition (luminal BC)
miR-224 DOWN CDC42, CXCR4 Invasion, metastasis inhibition
miR-31 DOWN WAVE3 Invasive phenotype reduction
miR-126 DOWN CXCL12 Metastasis inhibition
miR-124a DOWN Proliferation and metastasis inhibition
miR-708 DOWN LSD1 Proliferation, invasion inhibition
miR-30 DOWN UBC9 Self-renewal
let-7 DOWN H-RAS, HMGA2 Self-renewal, stemness
miR-590 DOWN SOX2 Stemness
miR-140 DOWN SOX2 Stemness, self-renewal
miR-183 cluster DOWN BMI1 Stemness, self-renewal

References

  1. MicroRNAs contribute to breast cancer invasiveness, Fridichova et al., Cell, 2019

siRNA Kits for Breast Cancer Research

OriGene's siRNA kits provide researchers with a comprehensive and efficient toolkit for targeted gene silencing and exploration. Each siRNA kit contains three unique 27mer siRNA duplexes (2 nmol each), a negative control, and dedicated buffer for seamless experimentation. There is also guaranteed knockdown of at least 70%!

Directions: Enter your gene name and select one item from each dropdown option, then press submit to view the siRNA kits we offer for your research.


Bulk Order Options

If you purchased our kits and already know which one works best for your gene, you can order this single siRNA in bulk by submitting a bulk request form. Each 10 nmol of single siRNA duplex is charged for $375. Delivery time is around 2 weeks.

Popular siRNA Kits for Breast Cancer Research

BRCA1 HER2 CHEK2 STK11 P53

shRNA Kits for Breast Cancer Research

Explore our HuSH-29TM shRNA Kits, engineered to deliver guaranteed knockdown efficiency of over 70% for each target gene. Available in both lentiviral and retroviral vectors, these comprehensive kits empower researchers with tailored solutions for effective gene silencing. Each kit features four distinct 29mer shRNA constructs designed for precise and robust knockdown, alongside a scramble control for reliable experimental validation.

Directions: Enter your gene name and select one item from each dropdown option, then press submit to view the shRNA kits we offer for your research.

Don't see what you're looking for? Check out our custom shRNA service here.


Transduction-ready Viral Particles Breast Cancer Research

Lentivirus and AAV (Adeno-associated virus) Particles

Viral particles are tools frequently used to deliver genetic material into cells. Lentiviral particles (LV) and adeno-associated viral particles (AAV) can deliver genetic material into dividing and non-dividing cells unlike other retroviral vectors. These two vectors remain the most popular options for gene delivery in both research and clinical application. OriGene offers pre-made, transduction-ready particles for popular genes in breast cancer research.

Lentivirus Product Format: 200ul; 10^7 TU/mL

AAV Product Format: 250ul; 10^13 GC/mL

Directions: Enter your gene name and select one item from each dropdown option, then press submit to view the viral particles we offer for your research.

Don't see what you're looking for? Check out our custom lentivirus service here.

Don't see what you're looking for? Check out our custom aav service here.

Popular Lentivirus Particles for Breast Cancer Research


CRISPR Knockout Kits for Breast Cancer Research

Our CRISPR Knockout Kits offer an efficient and reliable solution for researchers investigating gene function and disease mechanisms. These kits are easy to use and come with all the necessary components for successful gene editing, including pre-designed guide RNAs and vectors. Browse this collection of over 44,000 kits today!

Directions: Enter your gene name and select one item from each dropdown option, then press submit to view the knockout kits we offer for your research.

Don't see what you're looking for? Check out our custom CRISPR service here.


Tissues for Breast Cancer Research

OriGene's TissueScan cDNA arrays stand as pillars in breast cancer research, widely acknowledged and cited for their pivotal role in advancing scientific understanding (View citations). These arrays, encapsulating Tissue qPCR Arrays, offer panels of pre-normalized cDNA derived from a diverse array of cancer tissues, typically encompassing 48 samples across various disease stages.

Accompanied by comprehensive pathology reports, each array provides a holistic view of disease progression within specific tissue types. Through the design of gene-specific or SNP-specific primers, researchers can leverage a single real-time PCR reaction to unveil critical insights, including the dynamics of expression profile changes throughout disease progression for particular transcripts, comprehensive SNP profiling across disease stages, validation of potential biomarker candidates obtained from microarray data, and an in-depth exploration of the relevance of potential tumor suppressors or oncogenes across diverse cancer types.

We also offer Frozen Sections, Blocks, Tissue Protein Lysates, FFPE Sections, and More! View more Breast Cancer Tissue Products Here.

TissueScan Panels for Breast Cancer

Name Description Size Cat #
TissueScan, Breast Cancer cDNA Array I 48 samples covering 7-normal, 10- Stage I, 13-IIA, 7-IIB, 8-IIIA, 3-IIIC. 2 panels [BCRT101]
TissueScan Breast Cancer Tissue qPCR Panel I (5) containing five identical sets of 48 tissues covering four disease stages and normal tissues. 5 panels [BCRT301]
TissueScan Breast Cancer Tissue qPCR Panel I (10) containing ten identical sets of 48 tissues covering four disease stages and normal tissues. 10 panels [BCRT501]
TissueScan, Breast Cancer cDNA Array II 48 samples covering 5-normal, 11-Stage I, 8-IIA, 6-IIB, 8-IIIA, 2-IIIB, 4-IIIC, 4-IV. 2 panels [BCRT102]
TissueScan Breast Cancer Tissue qPCR Panel II (5) containing five identical sets of 48 tissues covering four disease stages and normal tissues. 5 panels [BCRT302]
TissueScan Breast Cancer Tissue qPCR Panel II (10) containing ten identical sets of 48 tissues covering four disease stage and normal tissues. 10 panels [BCRT502]
TissueScan, Breast Cancer cDNA Array III 48 samples covering 12-Stage I, 6-IIA, 10-IIB, 7-IIIA, 3-IIIB, 5-IIIC, 5-IV. 2 panels [BCRT103]
TissueScan Breast Cancer Tissue qPCR Panel III (5) containing five identical sets of 48 tissues covering four disease stage tissues. 5 panels [BCRT303]
TissueScan Breast Cancer Tissue qPCR Panel III (10) containing ten identical sets of 48 tissues covering four disease stage tissues. 10 panels [BCRT503]
miR-22 UP TET1-3 EMT, stemness
TissueScan, Breast Cancer cDNA Array IV 48 samples covering 4-normal, 2-Stage I, 15-IIA, 9-IIB, 7-IIIA, 4-IIIB, 6-IIIC, 1-IV. 2 panels [BCRT104]
TissueScan Breast Cancer Tissue qPCR Panel IV (5) containing five identical sets of 48 tissues covering four disease stage tissues. 5 panels [BCRT304]
TissueScan Breast Cancer Tissue qPCR Panel IV (10) containing ten identical sets of 48 tissues covering four disease stage tissues. 10 panels [BCRT504]

We also offer Frozen Sections, Blocks, Tissue Protein Lysates, FFPE Sections, and More! View more Breast Cancer Tissue Products Here.